Journal article

Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome


Authors listKralisch, S; Blüher, M; Paschke, R; Stumvoll, M; Fasshauer, M

Publication year2007

Pages39-45

JournalMini-Reviews in Medicinal Chemistry

Volume number7

Issue number1

ISSN1389-5575

DOI Linkhttps://doi.org/10.2174/138955707779317821

PublisherBentham Science Publishers


Abstract
The role of adipocytes has been recently better understood. Several adipocytokines have been identified, including leptin, a main regulator of appetite and energy expenditure, adiponectin and others, as novel insulin-sensitizers/insulin-mimetics, and some others inducing insulin resistance. Adipocytokines thus represent interesting novel drug targets in the future management of obesity.



Citation Styles

Harvard Citation styleKralisch, S., Blüher, M., Paschke, R., Stumvoll, M. and Fasshauer, M. (2007) Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome, Mini-Reviews in Medicinal Chemistry, 7(1), pp. 39-45. https://doi.org/10.2174/138955707779317821

APA Citation styleKralisch, S., Blüher, M., Paschke, R., Stumvoll, M., & Fasshauer, M. (2007). Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome. Mini-Reviews in Medicinal Chemistry. 7(1), 39-45. https://doi.org/10.2174/138955707779317821


Last updated on 2025-21-05 at 16:22